Aytu Bioscience (AYTU) to report earnings Thursday

Aytu Bioscience (AYTU) is expected to report First Quarter Fiscal 2021 Results and Provide Business Update on Thursday, November 12, 2020.

In the last earnings report, the company had a net revenue increase of 82% and a 766% year-over-year to $14.9 million. The company also had it’s highest revenue quarter which comes to 2x the entire fiscal 2019 revenue.

In the forth quarter, consumer health net revenue was $6.9 million compared to $3.5 million in the third quarter, respectively Rx net revenue and net loss in the fourth quarter was $7.9 million and -$3.1 million. The company also produced cash equivalents and restricted cash of $48.3 million on June 30, 2020, after fully extinguishing the $15 million Deerfield balloon payment obligation.

Expectations for Aytu Bioscience (AYTU)’s earnings report

Based on our analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.06. The reported EPS for the same quarter last year was $-0.32. While investor sentiment may have decreased, we expect that the price target will trade around $3 minimum in the coming months ahead.

Default image
Tim Rolle
Investor of 6 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research.
Articles: 117

Newsletter Updates

Enter your email address below to subscribe to our newsletter